Growth Metrics

Myomo (MYO) EBIAT (2016 - 2025)

Myomo's EBIAT history spans 10 years, with the latest figure at -$3.7 million for Q3 2025.

  • For Q3 2025, EBIAT fell 279.02% year-over-year to -$3.7 million; the TTM value through Sep 2025 reached -$12.0 million, down 43.37%, while the annual FY2024 figure was -$6.2 million, 24.1% up from the prior year.
  • EBIAT reached -$3.7 million in Q3 2025 per MYO's latest filing, up from -$4.6 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$260081.0 in Q4 2024 to a low of -$4.6 million in Q2 2025.
  • Average EBIAT over 5 years is -$2.5 million, with a median of -$2.6 million recorded in 2023.
  • Peak YoY movement for EBIAT: soared 89.43% in 2024, then plummeted 312.98% in 2025.
  • A 5-year view of EBIAT shows it stood at -$2.7 million in 2021, then increased by 20.7% to -$2.2 million in 2022, then dropped by 13.5% to -$2.5 million in 2023, then skyrocketed by 89.43% to -$260081.0 in 2024, then plummeted by 1308.38% to -$3.7 million in 2025.
  • Per Business Quant, the three most recent readings for MYO's EBIAT are -$3.7 million (Q3 2025), -$4.6 million (Q2 2025), and -$3.5 million (Q1 2025).